Effective March 1, 2022, separate reimbursement is not allowed for specimen validity testing when utilized for drug screening. Reimbursement is included in the CPT® and HCPCS code descriptions for presumptive and definitive drug testing. Modifier 59, XE, XP, XS, and XU will not be allowed to override. 


For additional information, please review the Drug Screen Testing reimbursement policy at https://www.empireblue.com/medicareprovider.


EBSCRNU-0198-21 October 2021

Featured In:
December 2021 Newsletter